scorecard

You Searched For "keytruda" and got 19 results


Sort By:


Business Insider Latest Story Image
1 min read

Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trial

The pharma giant said combining its cancer vaccine with Merck's Keytruda therapy reduced patients' …

Phil Rosen   


Business Insider Latest Story Image
4 mins read

We spoke with a key Merck executive about the strategy for its top cancer drug, a $7 billion powerhouse that could soon bring in more than $20 billion

The drugmaker has also tried to reach cancers that haven't responded well to other medicines with c…

Emma Court   


Business Insider Latest Story Image
3 mins read

A new kind of treatment is working better than chemotherapy in some lung cancer patients

"Immunotherapy with checkpoint inhibitors will displace chemotherapy in yet another subset of patie…

Lydia Ramsey   


Business Insider Latest Story Image
4 mins read

One crucial quote from Merck CEO Ken Frazier at an event for big-time investors in Manhattan shows the US drug giant at a crossroads

After nearly a decade of leadership by Frazier, Merck is preparing for transition at the top, thoug…

Emma Court   


Business Insider Latest Story Image
2 mins read

Here's why the drug that helped Jimmy Carter get 'cancer-free' is such a big deal

In someone with melanoma, certain proteins called PD-1 stop the immune system from doing its job an…

Lydia Ramsey   


Business Insider Latest Story Image
2 mins read

Merck climbs after announcing massive growth for its top cancer drug, which is now on pace to generate $10 billion a year

The bulk of the company's sales win came from Keytruda, a cancer treatment that uses the immune sys…

Ben Winck   


Business Insider Latest Story Image
2 mins read

2 massive drugmakers are locked in a battle over the market for cancer immunotherapy - Goldman analysts say one is pulling ahead

Last Thursday, Merck announced positive phase 3 results for its treatment of advanced or metastatic…

Charlotte Hu   


Business Insider Latest Story Image
2 mins read

Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine

The move is welcomed by investors because if successful, it would help Moderna diversify its revenu…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

There's a major roadblock to one of the most talked about new cancer therapies

It means finding a unique course of treatment that is tailored toward a cancer tumor's particular c…

Lydia Ramsey   


Business Insider Latest Story Image
3 mins read

Regeneron's coming late to a group of drugs that's already worth billions - here's why the company thinks it can still compete

If it turns out that finding the cancers that are driven by the immune system is key to getting imm…

Lydia Ramsey   


Business Insider Latest Story Image
5 mins read

'We are going to have lung cancer patients living longer and better:' A new kind of cancer treatment is about to change how we treat the disease

Progression-free survival - a clinical endpoint that basically means the cancer hasn't grown - was …

Lydia Ramsey   


Business Insider Latest Story Image
5 mins read

Jimmy Carter is no longer being treated for cancer - Here's why treatments like the one he used are suddenly gaining traction

In fact, roughly 30% of metastatic melanoma patients using Keytruda alone respond completely. That'…

Lydia Ramsey   


Business Insider Latest Story Image
5 mins read

Why cancer treatments like the one Jimmy Carter used are suddenly gaining traction

In fact, roughly 30% of metastatic melanoma patients using Keytruda alone respond completely. That'…

Lydia Ramsey   


Business Insider Latest Story Image
2 mins read

Bristol-Myers Squibb won't be going after a fast approval for its lung cancer drug

But not everybody responds to the PD-1 drugs. Just a quarter to a third of non-small cell lung canc…

Lydia Ramsey,Reuters   


Business Insider Latest Story Image
2 mins read

Andrew Dunn   


Business Insider Latest Story Image
2 mins read

One failed study shows just how fiercely competitive a new field of cancer therapy is

Opdivo, which has already been approved to treat other forms of cancer, has been a big hit for BMS,…

Lydia Ramsey   


Business Insider Latest Story Image
4 mins read

We're in the middle of a cancer-drug-innovation gold rush - but it has one major side effect

Within immunotherapy, researchers are trying to figure out how to get more people to respond to tre…

Lydia Ramsey   


Business Insider Latest Story Image
2 mins read

The FDA just took an entirely new approach to approving a cancer drug

On Tuesday, the agency approved pembolizumab (also known as Keytruda) to treat "unresectable or met…

Lydia Ramsey   


Business Insider Latest Story Image
6 mins read

A new kind of cancer treatment works remarkably well for some patients but not others - and researchers want to know why

But even with this level of excitement, and anecdotal cases like Carter and Schoenbauer, there are …

Lydia Ramsey